Piotr Garnuszek Selected Research

Radiopharmaceuticals

10/2022	[99mTc]Tc-PSMA-T4-Novel SPECT Tracer for Metastatic PCa: From Bench to Clinic.
1/2017	New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
8/2016	Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patients.
4/2012	Radiopharmaceuticals in cardiology.
4/2003	Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piotr Garnuszek Research Topics

Disease

12	Neoplasms (Cancer) 03/2023 - 02/2002
7	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 08/2009
5	Thyroid Neoplasms (Thyroid Cancer) 01/2019 - 03/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2022 - 01/2015
2	Neoplasm Metastasis (Metastasis) 03/2021 - 04/2003
2	Adenocarcinoma 07/2008 - 01/2005
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2023
1	Tachycardia (Tachyarrhythmias) 01/2023
1	Flushing 01/2023
1	medullary Thyroid cancer 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 05/2021
1	Lymphoma (Lymphomas) 10/2020
1	Inflammation (Inflammations) 01/2017
1	Infections 01/2017
1	Insulinoma 01/2016
1	Heart Diseases (Heart Disease) 04/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2012
1	Atherosclerotic Plaque (Atheroma) 04/2012
1	Experimental Neoplasms 07/2008
1	Colonic Neoplasms (Colon Cancer) 01/2004
1	Pain (Aches) 04/2003
1	Spondylarthropathies 04/2003
1	Breast Neoplasms (Breast Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

5	Peptides (Polypeptides)IBA 01/2023 - 01/2005
5	RadiopharmaceuticalsIBA 10/2022 - 04/2003
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2023 - 08/2009
4	Radioisotopes (Radionuclides)IBA 03/2023 - 01/2004
4	LigandsIBA 01/2023 - 03/2021
4	PlatinumIBA 07/2008 - 01/2002
3	Cholecystokinin B ReceptorIBA 01/2023 - 03/2016
3	Cytostatic AgentsIBA 07/2008 - 01/2002
2	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2023 - 12/2020
2	Rituximab (Mabthera)FDA Link 12/2022 - 01/2015
2	Chelating AgentsIBA 12/2022 - 10/2020
2	BombesinIBA 01/2021 - 08/2009
2	Cholecystokinin (Pancreozymin)IBA 08/2016 - 03/2016
2	Histamine (Histamine Dihydrochloride)FDA Link 07/2008 - 01/2004
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2023
1	PSMA I&TIBA 03/2023
1	Monoclonal AntibodiesIBA 12/2022
1	Urea (Carbamide)FDA LinkGeneric 10/2022
1	Hormones (Hormone)IBA 10/2022
1	GalliumIBA 10/2021
1	AntigensIBA 10/2021
1	EnzymesIBA 05/2021
1	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 01/2021
1	DOTA-NHSIBA 10/2020
1	177Lu-DOTA-rituximabIBA 10/2020
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 04/2018
1	exametazime FDA Link 01/2017
1	Technetium (Technetium 99m)IBA 01/2017
1	GastrinsIBA 08/2016
1	minigastrinIBA 03/2016
1	Exenatide (Byetta)FDA Link 01/2016
1	EDDA (NiEDDA)IBA 01/2016
1	Interleukin-2 (IL2)IBA 04/2012
1	Gastrin-Releasing PeptideIBA 08/2009
1	IodineIBA 07/2008
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	AcidsIBA 04/2003
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 04/2003
1	technetium Tc 99m ethylenediamine-tetramethylenephosphonic acidIBA 04/2003
1	Cisplatin (Platino)FDA LinkGeneric 02/2002

Therapy/Procedure

6	Therapeutics 03/2023 - 04/2018
5	Precision Medicine 01/2023 - 04/2018
3	Radiotherapy 08/2009 - 02/2002
2	Radioimmunotherapy 12/2022 - 10/2020
1	Palliative Care (Palliative Therapy) 10/2021
1	Castration 05/2021
1	Drug Therapy (Chemotherapy) 02/2002
1	Intraperitoneal Injections 02/2002